ARA-290 Dosage Calculator & Research Doses

1Set Up Your Mix

8 mg/mL · 8000 mcg/mL

1. Pick your peptide

2. How much peptide is in the vial? It's printed on the label — usually something like 5 mg

3. How much water are you adding? More water makes each dose easier to measure

4. How much do you want per dose?

All answers assume a standard 1 mL U-100 syringe, where 1 unit = 0.01 mL. That is the usual insulin syringe and the one every number here is based on.

Your Answer — ARA-290Your Answer

—

25Draw To This Line

0.25That's This Many mL

8Doses In The Vial

16 mg ÷ 2 mL = 8 mg/mL → 2 mg ÷ 8 mg/mL = 0.25 mL → × 100 = 25 units—

Looks good. Draw to 25 units on a 1 mL syringe. That is an easy amount to measure, and this vial gives you 8 doses.

2Week-By-Week Plan — ARA-290

Start low, work up

When	Dose	How Often	How Many mL	Draw To	Number Of Doses
Trial dose	4 mg	daily ×28 days	0.5 mL	50 u	4 doses
Trial dose	2 mg	daily	0.25 mL	25 u	8 doses
Extended	4 mg	daily, longer courses	0.5 mL	50 u	4 doses

Weeks until the top dose

2 weeks

Peptide used getting there

28 mg

Vials you'll need

2 × 16 mg

Once you're at the top dose

112 mg / 4 wk · 7 vials

Where this plan came from

Built from this peptide's dose range

Where this came from: Built from the doses listed for this peptide below — start at the lowest and step up, using the studies cited on this page. Nobody publishes a week-by-week plan for this peptide, so we built one: the doses are the researched ones shown below, and we simply put them in order from lowest to highest. Treat it as a starting point, not an official schedule.

3Common Doses — ARA-290

worked out for your mix

Level	Dose	How Often	How Many mL	Draw To	Doses In Vial
Weeks 1–2	2 mg	daily	0.25 mL	25 u	14	28 mg
Week 3 onward per 4 weeks from here on	4 mg	daily	0.5 mL	50 u	28	112 mg

Please read this. These numbers come from published research. They are here as reference, not as instructions. A lot of them come from lab studies rather than studies in people, and some of these peptides have never been given to a person at all.

About ARA-290About This Peptide

Cognitive & Neuro

Also known as

Cibinetide, EPO helix-B surface peptide

Class

Cognitive & Neuro

Route

Subcutaneous

Half-life

~2 min (tissue effect far longer)

Evidence tier

Clinical

An 11-amino-acid erythropoietin derivative that engages the innate repair receptor without the erythropoietic or thrombotic effects of EPO. Studied in sarcoidosis-associated small fibre neuropathy and diabetic neuropathy with genuine registered trials.

Buy ARA-290this peptide

Opens optimal-pep.com in a new tab

Where These Numbers Come From

Clinical — Human trial or approved-label dosing published

ARA 290 improves symptoms in patients with sarcoidosis-associated small nerve fibre loss Dahan A, et al. Molecular Medicine, 2013

The primary randomised human trial; source of the 4 mg daily figure.

Find on PubMed ↗

Erythropoietin-derived non-erythropoietic peptides and tissue protection Brines M, Cerami A. Journal of Internal Medicine, 2008

Mechanistic basis — the innate repair receptor concept.

Find on PubMed ↗

Newest Studies — —

—

Not reviewed by us. This list is pulled straight from Europe PMC as papers are published. Nobody has checked whether these are any good, or whether they change anything above. The dose numbers on this page only ever change after a person reviews the evidence.

Research Use Only — Confirm to Continue

ARA-290 Dosage & Reconstitution

1Set Up Your Mix

Your Answer — ARA-290Your Answer

2Week-By-Week Plan — ARA-290

3Common Doses — ARA-290

About ARA-290About This Peptide

Where These Numbers Come From

Newest Studies — —

More peptides

PE-22-28

Thymosin Alpha-1

All 71 peptides